. Author manuscript; available in PMC: 2021 Apr 1.

Published in final edited form as: World J Urol. 2019 Jun 7;38(4):949–956. doi: 10.1007/s00345-019-02835-2

Table 3.

Prostate cancer detection according to multiparametric MRI findings.

MRI findings	One-Stop pathway (n=74)	Standard pathway (n=296)	p-value
PI-RADS 1–2 (n=107)	23	84
PCa	11 (48%)	28 (33%)	0.2
csPCa	5 (22%)	14 (17%)	0.55
PI-RADS 3–5 (n=263)	51	212
PCa	34 (67%)	126 (59%)	0.20
csPCa	25 (49%)	87 (41%)	0.55
PI-RADS 3 (n=200)	36	164
PCa	20 (56%)	88 (54%)	0.84
csPCa	12 (33%)	54 (33%)	0.96
PI-RADS 4 (n=39)	8	31
PCa	7 (88%)	24 (77%)	0.53
csPCa	6 (75%)	20 (65%)	0.57
PI-RADS 5 (n=24)	7	17
PCa	7 (100%)	14 (82%)	0.23
csPCa	7 (100%)	13 (76%)	0.16

PCa, prostate cancer; csPCa, clinically significant PCa; MRI, magnetic resonance imaging; n= number of patients; PI-RADS, Prostate Imaging and Reporting Data System.